Seung Up Kim

Associate professor

Yonsei University

South Korea

Research Interests

Explore related searches

About

Seung Up Kim is an Associate Professor at Yonsei University in South Korea. His research primarily focuses on liver diseases, including metabolic dysfunction-associated steatotic liver disease, hepatocellular carcinoma, and the impact of antiviral therapies on liver fibrosis. He has published several recent articles addressing innovative treatment approaches and the identification of biomarkers related to liver cancer.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (22)

Jong Ryeol Eun

Professor

Hanyang University College of Medicine

SOUTH KOREA

Seung Up Kim

Research Interests

Explore related searches

About

Articles (29)

Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease

Identification of new biomarkers of hepatic cancer stem cells through proteomic profiling

Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma

Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance

Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease

Reply to: “Unlock AI-Safe-C score's potential at all levels: Improve methods and overcome barriers”

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C

Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Correspondence to editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis”

Correspondence to editorial on “Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”

Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere

Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity

Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease

Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease

Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma

Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center

Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities

High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States

The utility of fusion imaging technique for evaluation of ultrasound quality in surveillance of hepatocellular carcinoma

Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis

Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes

Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy

Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study

Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study

Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future

Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adults

Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease

Collaborators (22)

Jong Ryeol Eun

Beom Kyung Kim

Dae Won Jun

Jong Yun Won

Mi Na Kim

Yoon Jun Kim

TAE SEOP LIM

Hyeok-Hee Lee

Minjong Lee

Yeon Seok Seo

Chan-Young Jung

Do Young Kim

Sun Jae Jung

Hannes Hagström

Eugene Han

Jae Youn Cheong

Hyeon Chang Kim

Sang Gyune Kim

Soon Sun Kim

Moon Young Kim

Jihye Kim

Beom Seok Kim

Make your next move.